Onc.AI Stock

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

Sign up today and learn more about Onc.AI Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Onc.AI Stock

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Funding History

December 2020$6.0M
January 2023$25.0M

Management

Co-Founder and CEO

Akshay Nanduri

Board Advisor / Investor

Thomas Hawes

Board Member

Julie Hambleton

Chairman Of The Board

Jonathan J. Fleming

Member, Board of Directors

Emir Sandhu

Member, Board of Directors

David Diaz-Casariego

VP Software and Founder

Salmaan Ahmed

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo